nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP2D6—Gefitinib—lung cancer	0.0685	0.125	CbGbCtD
Prochlorperazine—CYP2D6—Vinorelbine—lung cancer	0.0528	0.096	CbGbCtD
Prochlorperazine—CYP3A4—Topotecan—lung cancer	0.0476	0.0867	CbGbCtD
Prochlorperazine—CYP3A4—Gefitinib—lung cancer	0.0436	0.0793	CbGbCtD
Prochlorperazine—CYP3A4—Teniposide—lung cancer	0.0423	0.0769	CbGbCtD
Prochlorperazine—CYP2D6—Erlotinib—lung cancer	0.0405	0.0737	CbGbCtD
Prochlorperazine—CYP3A4—Vinorelbine—lung cancer	0.0336	0.0611	CbGbCtD
Prochlorperazine—CYP2D6—Vinblastine—lung cancer	0.0325	0.0592	CbGbCtD
Prochlorperazine—CYP3A4—Crizotinib—lung cancer	0.0267	0.0486	CbGbCtD
Prochlorperazine—CYP3A4—Erlotinib—lung cancer	0.0258	0.0469	CbGbCtD
Prochlorperazine—CYP3A4—Paclitaxel—lung cancer	0.0236	0.0429	CbGbCtD
Prochlorperazine—CYP3A4—Irinotecan—lung cancer	0.0233	0.0423	CbGbCtD
Prochlorperazine—CYP3A4—Vinblastine—lung cancer	0.0207	0.0376	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—lung cancer	0.02	0.0364	CbGbCtD
Prochlorperazine—CYP3A4—Etoposide—lung cancer	0.0186	0.0339	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—lung cancer	0.017	0.031	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—lung cancer	0.0127	0.0231	CbGbCtD
Prochlorperazine—Clomipramine—GSTP1—lung cancer	0.000521	0.0832	CrCbGaD
Prochlorperazine—Dermatitis contact—Doxorubicin—lung cancer	0.000497	0.00153	CcSEcCtD
Prochlorperazine—Erythema—Gemcitabine—lung cancer	0.000496	0.00153	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vinorelbine—lung cancer	0.000493	0.00152	CcSEcCtD
Prochlorperazine—Muscle spasms—Irinotecan—lung cancer	0.000489	0.00151	CcSEcCtD
Prochlorperazine—Skin disorder—Vinorelbine—lung cancer	0.000489	0.00151	CcSEcCtD
Prochlorperazine—Photosensitivity—Methotrexate—lung cancer	0.00048	0.00148	CcSEcCtD
Prochlorperazine—Pancytopenia—Docetaxel—lung cancer	0.00048	0.00148	CcSEcCtD
Prochlorperazine—Arrhythmia—Cisplatin—lung cancer	0.000474	0.00146	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—lung cancer	0.000472	0.00145	CcSEcCtD
Prochlorperazine—Hypotension—Vinorelbine—lung cancer	0.000471	0.00145	CcSEcCtD
Prochlorperazine—Oedema peripheral—Paclitaxel—lung cancer	0.00047	0.00145	CcSEcCtD
Prochlorperazine—Urticaria—Topotecan—lung cancer	0.000468	0.00144	CcSEcCtD
Prochlorperazine—Body temperature increased—Topotecan—lung cancer	0.000466	0.00143	CcSEcCtD
Prochlorperazine—Erythema—Cisplatin—lung cancer	0.000462	0.00142	CcSEcCtD
Prochlorperazine—Body temperature increased—Erlotinib—lung cancer	0.000461	0.00142	CcSEcCtD
Prochlorperazine—Erythema multiforme—Etoposide—lung cancer	0.00046	0.00142	CcSEcCtD
Prochlorperazine—Weight increased—Docetaxel—lung cancer	0.00046	0.00142	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—lung cancer	0.000459	0.00141	CcSEcCtD
Prochlorperazine—Leukopenia—Irinotecan—lung cancer	0.000456	0.0014	CcSEcCtD
Prochlorperazine—Erythema multiforme—Paclitaxel—lung cancer	0.000451	0.00139	CcSEcCtD
Prochlorperazine—Dyspnoea—Vinorelbine—lung cancer	0.000449	0.00138	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinblastine—lung cancer	0.000447	0.00137	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000446	0.00137	CcSEcCtD
Prochlorperazine—Muscle spasms—Cisplatin—lung cancer	0.000444	0.00137	CcSEcCtD
Prochlorperazine—Cough—Irinotecan—lung cancer	0.000444	0.00137	CcSEcCtD
Prochlorperazine—Leukopenia—Gemcitabine—lung cancer	0.000444	0.00137	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—lung cancer	0.000439	0.00135	CcSEcCtD
Prochlorperazine—Vision blurred—Cisplatin—lung cancer	0.000436	0.00134	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000435	0.00134	CcSEcCtD
Prochlorperazine—Hypersensitivity—Topotecan—lung cancer	0.000434	0.00134	CcSEcCtD
Prochlorperazine—Tremor—Cisplatin—lung cancer	0.000433	0.00133	CcSEcCtD
Prochlorperazine—Cough—Gemcitabine—lung cancer	0.000433	0.00133	CcSEcCtD
Prochlorperazine—Constipation—Vinorelbine—lung cancer	0.000431	0.00133	CcSEcCtD
Prochlorperazine—Arrhythmia—Paclitaxel—lung cancer	0.000426	0.00131	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—lung cancer	0.00042	0.00129	CcSEcCtD
Prochlorperazine—Pruritus—Topotecan—lung cancer	0.000417	0.00128	CcSEcCtD
Prochlorperazine—Oedema—Irinotecan—lung cancer	0.000416	0.00128	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Irinotecan—lung cancer	0.000416	0.00128	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—lung cancer	0.000415	0.00128	CcSEcCtD
Prochlorperazine—Erythema—Paclitaxel—lung cancer	0.000415	0.00128	CcSEcCtD
Prochlorperazine—Leukopenia—Cisplatin—lung cancer	0.000414	0.00127	CcSEcCtD
Prochlorperazine—Infection—Irinotecan—lung cancer	0.000413	0.00127	CcSEcCtD
Prochlorperazine—Pruritus—Erlotinib—lung cancer	0.000412	0.00127	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—lung cancer	0.000407	0.00125	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Irinotecan—lung cancer	0.000407	0.00125	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—lung cancer	0.000406	0.00125	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Gemcitabine—lung cancer	0.000405	0.00125	CcSEcCtD
Prochlorperazine—Oedema—Gemcitabine—lung cancer	0.000405	0.00125	CcSEcCtD
Prochlorperazine—Nervousness—Paclitaxel—lung cancer	0.000403	0.00124	CcSEcCtD
Prochlorperazine—Infection—Gemcitabine—lung cancer	0.000402	0.00124	CcSEcCtD
Prochlorperazine—Dizziness—Vinblastine—lung cancer	0.000401	0.00123	CcSEcCtD
Prochlorperazine—Convulsion—Cisplatin—lung cancer	0.000401	0.00123	CcSEcCtD
Prochlorperazine—Urticaria—Vinorelbine—lung cancer	0.0004	0.00123	CcSEcCtD
Prochlorperazine—Muscle spasms—Paclitaxel—lung cancer	0.000399	0.00123	CcSEcCtD
Prochlorperazine—Body temperature increased—Vinorelbine—lung cancer	0.000398	0.00123	CcSEcCtD
Prochlorperazine—Oedema peripheral—Docetaxel—lung cancer	0.000398	0.00123	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Gemcitabine—lung cancer	0.000396	0.00122	CcSEcCtD
Prochlorperazine—Skin disorder—Gemcitabine—lung cancer	0.000393	0.00121	CcSEcCtD
Prochlorperazine—Vision blurred—Paclitaxel—lung cancer	0.000391	0.0012	CcSEcCtD
Prochlorperazine—Dizziness—Topotecan—lung cancer	0.000389	0.0012	CcSEcCtD
Prochlorperazine—Tremor—Paclitaxel—lung cancer	0.000389	0.0012	CcSEcCtD
Prochlorperazine—Hypotension—Irinotecan—lung cancer	0.000388	0.0012	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—lung cancer	0.000388	0.0012	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000387	0.00119	CcSEcCtD
Prochlorperazine—Dizziness—Erlotinib—lung cancer	0.000385	0.00119	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—lung cancer	0.000382	0.00118	CcSEcCtD
Prochlorperazine—Agitation—Paclitaxel—lung cancer	0.000382	0.00117	CcSEcCtD
Prochlorperazine—Headache—Vinblastine—lung cancer	0.00038	0.00117	CcSEcCtD
Prochlorperazine—Angioedema—Paclitaxel—lung cancer	0.000379	0.00117	CcSEcCtD
Prochlorperazine—Leukopenia—Etoposide—lung cancer	0.000379	0.00117	CcSEcCtD
Prochlorperazine—Hypotension—Gemcitabine—lung cancer	0.000378	0.00116	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Cisplatin—lung cancer	0.000377	0.00116	CcSEcCtD
Prochlorperazine—Oedema—Cisplatin—lung cancer	0.000377	0.00116	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000377	0.00116	CcSEcCtD
Prochlorperazine—Insomnia—Irinotecan—lung cancer	0.000376	0.00116	CcSEcCtD
Prochlorperazine—Infection—Cisplatin—lung cancer	0.000375	0.00115	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—lung cancer	0.000374	0.00115	CcSEcCtD
Prochlorperazine—Leukopenia—Paclitaxel—lung cancer	0.000372	0.00114	CcSEcCtD
Prochlorperazine—Rash—Topotecan—lung cancer	0.000371	0.00114	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinorelbine—lung cancer	0.000371	0.00114	CcSEcCtD
Prochlorperazine—Dermatitis—Topotecan—lung cancer	0.000371	0.00114	CcSEcCtD
Prochlorperazine—Dyspnoea—Irinotecan—lung cancer	0.00037	0.00114	CcSEcCtD
Prochlorperazine—Cough—Etoposide—lung cancer	0.00037	0.00114	CcSEcCtD
Prochlorperazine—Somnolence—Irinotecan—lung cancer	0.000369	0.00114	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Cisplatin—lung cancer	0.000369	0.00114	CcSEcCtD
Prochlorperazine—Headache—Topotecan—lung cancer	0.000369	0.00114	CcSEcCtD
Prochlorperazine—Rash—Erlotinib—lung cancer	0.000367	0.00113	CcSEcCtD
Prochlorperazine—Dermatitis—Erlotinib—lung cancer	0.000367	0.00113	CcSEcCtD
Prochlorperazine—Convulsion—Etoposide—lung cancer	0.000367	0.00113	CcSEcCtD
Prochlorperazine—Skin disorder—Cisplatin—lung cancer	0.000366	0.00113	CcSEcCtD
Prochlorperazine—Insomnia—Gemcitabine—lung cancer	0.000366	0.00113	CcSEcCtD
Prochlorperazine—Headache—Erlotinib—lung cancer	0.000365	0.00112	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—lung cancer	0.000364	0.00112	CcSEcCtD
Prochlorperazine—Cough—Paclitaxel—lung cancer	0.000362	0.00112	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—lung cancer	0.000361	0.00111	CcSEcCtD
Prochlorperazine—Dyspnoea—Gemcitabine—lung cancer	0.000361	0.00111	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—lung cancer	0.00036	0.00111	CcSEcCtD
Prochlorperazine—Somnolence—Gemcitabine—lung cancer	0.00036	0.00111	CcSEcCtD
Prochlorperazine—Convulsion—Paclitaxel—lung cancer	0.00036	0.00111	CcSEcCtD
Prochlorperazine—Pruritus—Vinorelbine—lung cancer	0.000356	0.0011	CcSEcCtD
Prochlorperazine—Constipation—Irinotecan—lung cancer	0.000355	0.00109	CcSEcCtD
Prochlorperazine—Hypotension—Cisplatin—lung cancer	0.000353	0.00109	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—lung cancer	0.000352	0.00108	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—lung cancer	0.000347	0.00107	CcSEcCtD
Prochlorperazine—Constipation—Gemcitabine—lung cancer	0.000346	0.00107	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—lung cancer	0.000346	0.00106	CcSEcCtD
Prochlorperazine—Dry mouth—Paclitaxel—lung cancer	0.000346	0.00106	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—lung cancer	0.000346	0.00106	CcSEcCtD
Prochlorperazine—Infection—Etoposide—lung cancer	0.000343	0.00106	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Paclitaxel—lung cancer	0.000339	0.00104	CcSEcCtD
Prochlorperazine—Oedema—Paclitaxel—lung cancer	0.000339	0.00104	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—lung cancer	0.000338	0.00104	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—lung cancer	0.000338	0.00104	CcSEcCtD
Prochlorperazine—Infection—Paclitaxel—lung cancer	0.000337	0.00104	CcSEcCtD
Prochlorperazine—Dyspnoea—Cisplatin—lung cancer	0.000336	0.00104	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—lung cancer	0.000336	0.00103	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—lung cancer	0.000335	0.00103	CcSEcCtD
Prochlorperazine—Dizziness—Vinorelbine—lung cancer	0.000333	0.00103	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000332	0.00102	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Paclitaxel—lung cancer	0.000332	0.00102	CcSEcCtD
Prochlorperazine—Skin disorder—Paclitaxel—lung cancer	0.000329	0.00101	CcSEcCtD
Prochlorperazine—Body temperature increased—Irinotecan—lung cancer	0.000328	0.00101	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—lung cancer	0.000325	0.000999	CcSEcCtD
Prochlorperazine—Hypotension—Etoposide—lung cancer	0.000323	0.000994	CcSEcCtD
Prochlorperazine—Body temperature increased—Gemcitabine—lung cancer	0.00032	0.000985	CcSEcCtD
Prochlorperazine—Rash—Vinorelbine—lung cancer	0.000318	0.000978	CcSEcCtD
Prochlorperazine—Dermatitis—Vinorelbine—lung cancer	0.000317	0.000977	CcSEcCtD
Prochlorperazine—Hypotension—Paclitaxel—lung cancer	0.000317	0.000975	CcSEcCtD
Prochlorperazine—Headache—Vinorelbine—lung cancer	0.000316	0.000972	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—lung cancer	0.000315	0.00097	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—lung cancer	0.000315	0.00097	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—lung cancer	0.000315	0.00097	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—lung cancer	0.000315	0.00097	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—lung cancer	0.000312	0.000961	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—lung cancer	0.000308	0.000949	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—lung cancer	0.000307	0.000946	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—lung cancer	0.000307	0.000945	CcSEcCtD
Prochlorperazine—Insomnia—Paclitaxel—lung cancer	0.000306	0.000943	CcSEcCtD
Prochlorperazine—Hypersensitivity—Irinotecan—lung cancer	0.000306	0.000942	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—lung cancer	0.000305	0.000939	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—lung cancer	0.000303	0.000932	CcSEcCtD
Prochlorperazine—Desipramine—CYP2A6—lung cancer	0.000303	0.0484	CrCbGaD
Prochlorperazine—Dyspnoea—Paclitaxel—lung cancer	0.000302	0.00093	CcSEcCtD
Prochlorperazine—Somnolence—Paclitaxel—lung cancer	0.000301	0.000927	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—lung cancer	0.000299	0.000922	CcSEcCtD
Prochlorperazine—Body temperature increased—Cisplatin—lung cancer	0.000298	0.000918	CcSEcCtD
Prochlorperazine—Constipation—Etoposide—lung cancer	0.000296	0.00091	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—lung cancer	0.000293	0.000902	CcSEcCtD
Prochlorperazine—Fluphenazine—CYP2E1—lung cancer	0.000292	0.0467	CrCbGaD
Prochlorperazine—Constipation—Paclitaxel—lung cancer	0.00029	0.000892	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000288	0.000886	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—lung cancer	0.000287	0.000884	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—lung cancer	0.000287	0.000884	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—lung cancer	0.000287	0.000883	CcSEcCtD
Prochlorperazine—Pruritus—Gemcitabine—lung cancer	0.000286	0.000882	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—lung cancer	0.000285	0.000878	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—lung cancer	0.000284	0.000875	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—lung cancer	0.000281	0.000866	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—lung cancer	0.000281	0.000865	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—lung cancer	0.000279	0.000859	CcSEcCtD
Prochlorperazine—Hypersensitivity—Cisplatin—lung cancer	0.000278	0.000856	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—lung cancer	0.000276	0.000848	CcSEcCtD
Prochlorperazine—Dizziness—Irinotecan—lung cancer	0.000275	0.000846	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—lung cancer	0.000275	0.000845	CcSEcCtD
Prochlorperazine—Clozapine—CYP2A6—lung cancer	0.000274	0.0438	CrCbGaD
Prochlorperazine—Jaundice—Doxorubicin—lung cancer	0.000274	0.000843	CcSEcCtD
Prochlorperazine—Body temperature increased—Etoposide—lung cancer	0.000273	0.000841	CcSEcCtD
Prochlorperazine—Urticaria—Paclitaxel—lung cancer	0.000269	0.000829	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—lung cancer	0.000268	0.000826	CcSEcCtD
Prochlorperazine—Body temperature increased—Paclitaxel—lung cancer	0.000268	0.000825	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—lung cancer	0.000262	0.000807	CcSEcCtD
Prochlorperazine—Rash—Irinotecan—lung cancer	0.000262	0.000806	CcSEcCtD
Prochlorperazine—Dermatitis—Irinotecan—lung cancer	0.000262	0.000806	CcSEcCtD
Prochlorperazine—Headache—Irinotecan—lung cancer	0.00026	0.000801	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—lung cancer	0.00026	0.0008	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—lung cancer	0.000256	0.000788	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—lung cancer	0.000255	0.000786	CcSEcCtD
Prochlorperazine—Rash—Gemcitabine—lung cancer	0.000255	0.000786	CcSEcCtD
Prochlorperazine—Dermatitis—Gemcitabine—lung cancer	0.000255	0.000785	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—lung cancer	0.000255	0.000784	CcSEcCtD
Prochlorperazine—Erythema—Methotrexate—lung cancer	0.000254	0.000781	CcSEcCtD
Prochlorperazine—Headache—Gemcitabine—lung cancer	0.000254	0.000781	CcSEcCtD
Prochlorperazine—Thioridazine—CYP2E1—lung cancer	0.000252	0.0402	CrCbGaD
Prochlorperazine—Hypersensitivity—Paclitaxel—lung cancer	0.00025	0.000769	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—lung cancer	0.000249	0.000765	CcSEcCtD
Prochlorperazine—Domperidone—ABCB1—lung cancer	0.000246	0.0393	CrCbGaD
Prochlorperazine—Constipation—Docetaxel—lung cancer	0.000246	0.000756	CcSEcCtD
Prochlorperazine—Pruritus—Etoposide—lung cancer	0.000245	0.000753	CcSEcCtD
Prochlorperazine—Methotrimeprazine—CYP2E1—lung cancer	0.00024	0.0384	CrCbGaD
Prochlorperazine—Pruritus—Paclitaxel—lung cancer	0.00024	0.000738	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—lung cancer	0.000239	0.000736	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—lung cancer	0.000239	0.000734	CcSEcCtD
Prochlorperazine—Rash—Cisplatin—lung cancer	0.000238	0.000732	CcSEcCtD
Prochlorperazine—Dermatitis—Cisplatin—lung cancer	0.000238	0.000732	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—lung cancer	0.000229	0.000704	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—lung cancer	0.000227	0.000699	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—lung cancer	0.000227	0.000699	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—lung cancer	0.000225	0.000694	CcSEcCtD
Prochlorperazine—Dizziness—Paclitaxel—lung cancer	0.000224	0.00069	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—lung cancer	0.000221	0.000681	CcSEcCtD
Prochlorperazine—Convulsion—Methotrexate—lung cancer	0.00022	0.000677	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—lung cancer	0.00022	0.000676	CcSEcCtD
Prochlorperazine—Rash—Etoposide—lung cancer	0.000218	0.000671	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—lung cancer	0.000218	0.00067	CcSEcCtD
Prochlorperazine—Headache—Etoposide—lung cancer	0.000217	0.000667	CcSEcCtD
Prochlorperazine—Desipramine—CYP2E1—lung cancer	0.000215	0.0343	CrCbGaD
Prochlorperazine—Rash—Paclitaxel—lung cancer	0.000214	0.000658	CcSEcCtD
Prochlorperazine—Dermatitis—Paclitaxel—lung cancer	0.000213	0.000657	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—lung cancer	0.000213	0.000657	CcSEcCtD
Prochlorperazine—Headache—Paclitaxel—lung cancer	0.000212	0.000654	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—lung cancer	0.000212	0.000651	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—lung cancer	0.000211	0.00065	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—lung cancer	0.000207	0.000637	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—lung cancer	0.000207	0.000637	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—lung cancer	0.000206	0.000633	CcSEcCtD
Prochlorperazine—Nefazodone—ABCB1—lung cancer	0.000204	0.0326	CrCbGaD
Prochlorperazine—Pruritus—Docetaxel—lung cancer	0.000203	0.000626	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—lung cancer	0.000203	0.000624	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—lung cancer	0.000202	0.000621	CcSEcCtD
Prochlorperazine—Skin disorder—Methotrexate—lung cancer	0.000201	0.000619	CcSEcCtD
Prochlorperazine—Triflupromazine—ABCB1—lung cancer	0.000199	0.0318	CrCbGaD
Prochlorperazine—Leukopenia—Doxorubicin—lung cancer	0.000197	0.000605	CcSEcCtD
Prochlorperazine—Clozapine—CYP2E1—lung cancer	0.000195	0.0311	CrCbGaD
Prochlorperazine—Hypotension—Methotrexate—lung cancer	0.000193	0.000595	CcSEcCtD
Prochlorperazine—Acepromazine—ALB—lung cancer	0.000193	0.0308	CrCbGaD
Prochlorperazine—Clozapine—CYP1A1—lung cancer	0.000192	0.0307	CrCbGaD
Prochlorperazine—Cough—Doxorubicin—lung cancer	0.000192	0.00059	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—lung cancer	0.00019	0.000586	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—lung cancer	0.00019	0.000585	CcSEcCtD
Prochlorperazine—Aripiprazole—ABCB1—lung cancer	0.00019	0.0303	CrCbGaD
Prochlorperazine—Trazodone—ABCB1—lung cancer	0.000189	0.0302	CrCbGaD
Prochlorperazine—Thioproperazine—ALB—lung cancer	0.000189	0.0301	CrCbGaD
Prochlorperazine—Insomnia—Methotrexate—lung cancer	0.000187	0.000576	CcSEcCtD
Prochlorperazine—Pipotiazine—ALB—lung cancer	0.000186	0.0297	CrCbGaD
Prochlorperazine—Thiothixene—ALB—lung cancer	0.000186	0.0297	CrCbGaD
Prochlorperazine—Dyspnoea—Methotrexate—lung cancer	0.000185	0.000568	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—lung cancer	0.000184	0.000567	CcSEcCtD
Prochlorperazine—Chlorpromazine—CYP2E1—lung cancer	0.000183	0.0293	CrCbGaD
Prochlorperazine—Dry mouth—Doxorubicin—lung cancer	0.000183	0.000563	CcSEcCtD
Prochlorperazine—Imipramine—CYP2E1—lung cancer	0.000182	0.0291	CrCbGaD
Prochlorperazine—Rash—Docetaxel—lung cancer	0.000181	0.000557	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—lung cancer	0.000181	0.000557	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—lung cancer	0.00018	0.000554	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—lung cancer	0.000179	0.000552	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—lung cancer	0.000179	0.000552	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—lung cancer	0.000178	0.000548	CcSEcCtD
Prochlorperazine—Clobazam—ABCB1—lung cancer	0.000177	0.0283	CrCbGaD
Prochlorperazine—Thrombocytopenia—Doxorubicin—lung cancer	0.000176	0.00054	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—lung cancer	0.000174	0.000536	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—lung cancer	0.000168	0.000516	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—lung cancer	0.000164	0.000506	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—lung cancer	0.000164	0.000504	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—lung cancer	0.000162	0.000499	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—lung cancer	0.00016	0.000492	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—lung cancer	0.000159	0.000491	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—lung cancer	0.000153	0.000472	CcSEcCtD
Prochlorperazine—Fluphenazine—ABCB1—lung cancer	0.000153	0.0245	CrCbGaD
Prochlorperazine—Hypersensitivity—Methotrexate—lung cancer	0.000153	0.00047	CcSEcCtD
Prochlorperazine—Clomipramine—ALB—lung cancer	0.000147	0.0234	CrCbGaD
Prochlorperazine—Pruritus—Methotrexate—lung cancer	0.000146	0.000451	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—lung cancer	0.000142	0.000438	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—lung cancer	0.000142	0.000436	CcSEcCtD
Prochlorperazine—Clomipramine—ABCB1—lung cancer	0.00014	0.0224	CrCbGaD
Prochlorperazine—Chlorprothixene—ABCB1—lung cancer	0.000139	0.0223	CrCbGaD
Prochlorperazine—Dizziness—Methotrexate—lung cancer	0.000137	0.000421	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—lung cancer	0.000132	0.000407	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—lung cancer	0.000131	0.000402	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—lung cancer	0.00013	0.000401	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—lung cancer	0.00013	0.000399	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—lung cancer	0.000127	0.00039	CcSEcCtD
Prochlorperazine—Promethazine—ABCB1—lung cancer	0.000124	0.0198	CrCbGaD
Prochlorperazine—Trifluoperazine—ABCB1—lung cancer	0.000122	0.0196	CrCbGaD
Prochlorperazine—Quetiapine—ABCB1—lung cancer	0.000119	0.019	CrCbGaD
Prochlorperazine—Dizziness—Doxorubicin—lung cancer	0.000119	0.000365	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—lung cancer	0.000113	0.000348	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—lung cancer	0.000113	0.000348	CcSEcCtD
Prochlorperazine—Desipramine—ABCB1—lung cancer	0.000113	0.018	CrCbGaD
Prochlorperazine—Headache—Doxorubicin—lung cancer	0.000112	0.000346	CcSEcCtD
Prochlorperazine—Clozapine—ABCB1—lung cancer	0.000102	0.0163	CrCbGaD
Prochlorperazine—Chlorpromazine—ALB—lung cancer	0.000101	0.0161	CrCbGaD
Prochlorperazine—Chlorpromazine—ABCB1—lung cancer	9.6e-05	0.0153	CrCbGaD
Prochlorperazine—Imipramine—ABCB1—lung cancer	9.55e-05	0.0153	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—MTOR—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CG—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—APC—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KIT—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—NRAS—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CD—lung cancer	1.51e-05	0.000126	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CAT—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ENO2—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—HPGDS—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGF—lung cancer	1.49e-05	0.000125	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.49e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PIK3CA—lung cancer	1.49e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—APC—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CG—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KIT—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—NRAS—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—KRAS—lung cancer	1.47e-05	0.000124	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGF—lung cancer	1.47e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ABCB1—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—APC—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KIT—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTT1—lung cancer	1.46e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CXCL8—lung cancer	1.46e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—MAPK3—lung cancer	1.45e-05	0.000122	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRAS—lung cancer	1.45e-05	0.000121	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGF—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GCLC—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—POMC—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TYMS—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—MAPK3—lung cancer	1.42e-05	0.000119	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—BRAF—lung cancer	1.42e-05	0.000119	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—GSTM1—lung cancer	1.42e-05	0.000119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—POMC—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—AKT1—lung cancer	1.41e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6R—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CREBBP—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.4e-05	0.000117	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—BRAF—lung cancer	1.4e-05	0.000117	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CASP3—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL2—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—POMC—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—IL6—lung cancer	1.38e-05	0.000116	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6R—lung cancer	1.38e-05	0.000116	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—EGFR—lung cancer	1.38e-05	0.000116	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CREBBP—lung cancer	1.38e-05	0.000115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—BRAF—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ENO1—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6R—lung cancer	1.36e-05	0.000114	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CCND1—lung cancer	1.36e-05	0.000114	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PIK3CA—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—JUN—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—EGFR—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MDM2—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—RAF1—lung cancer	1.34e-05	0.000113	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.34e-05	0.000112	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ERCC2—lung cancer	1.34e-05	0.000112	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ERBB2—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.32e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MMP9—lung cancer	1.32e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAP2K1—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CB—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MTOR—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—CDKN1A—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PTEN—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CD—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—KRAS—lung cancer	1.3e-05	0.000109	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	1.29e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.29e-05	0.000108	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.28e-05	0.000108	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—KRAS—lung cancer	1.28e-05	0.000107	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—AKT1—lung cancer	1.28e-05	0.000107	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.27e-05	0.000107	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CXCL8—lung cancer	1.26e-05	0.000106	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.26e-05	0.000105	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRAS—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EP300—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—AKT1—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—SRC—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—NQO1—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CASP3—lung cancer	1.21e-05	0.000101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL2—lung cancer	1.21e-05	0.000101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—IL6—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	1.2e-05	0.0001	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MDM2—lung cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RAF1—lung cancer	1.19e-05	9.96e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—VEGFA—lung cancer	1.18e-05	9.92e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CCND1—lung cancer	1.18e-05	9.86e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ERBB2—lung cancer	1.17e-05	9.85e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	9.85e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—JUN—lung cancer	1.17e-05	9.84e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—STAT3—lung cancer	1.17e-05	9.82e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MDM2—lung cancer	1.17e-05	9.81e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NRAS—lung cancer	1.17e-05	9.79e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RAF1—lung cancer	1.17e-05	9.78e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MTOR—lung cancer	1.16e-05	9.72e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CB—lung cancer	1.16e-05	9.72e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—APOA1—lung cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.16e-05	9.69e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.15e-05	9.67e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.15e-05	9.65e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RAF1—lung cancer	1.15e-05	9.62e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MMP9—lung cancer	1.14e-05	9.57e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.14e-05	9.55e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MTOR—lung cancer	1.14e-05	9.55e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—CDKN1A—lung cancer	1.14e-05	9.54e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PTEN—lung cancer	1.13e-05	9.52e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.13e-05	9.52e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MTOR—lung cancer	1.12e-05	9.39e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.12e-05	9.39e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MAPK3—lung cancer	1.12e-05	9.38e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CXCL8—lung cancer	1.11e-05	9.34e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—AKT1—lung cancer	1.11e-05	9.29e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRAS—lung cancer	1.11e-05	9.28e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.09e-05	9.17e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—STK11—lung cancer	1.09e-05	9.17e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—MYC—lung cancer	1.09e-05	9.12e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EP300—lung cancer	1.08e-05	9.08e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.08e-05	9.03e-05	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.08e-05	9.02e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.07e-05	8.97e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CASP3—lung cancer	1.07e-05	8.94e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL2—lung cancer	1.06e-05	8.93e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EGFR—lung cancer	1.06e-05	8.92e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—IL6—lung cancer	1.06e-05	8.88e-05	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.06e-05	8.86e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.05e-05	8.85e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—SRC—lung cancer	1.05e-05	8.83e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CASP3—lung cancer	1.05e-05	8.78e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL2—lung cancer	1.04e-05	8.77e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—IL6—lung cancer	1.04e-05	8.72e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.04e-05	8.72e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CCND1—lung cancer	1.04e-05	8.7e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—JUN—lung cancer	1.04e-05	8.69e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CASP3—lung cancer	1.03e-05	8.64e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL2—lung cancer	1.03e-05	8.63e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—VEGFA—lung cancer	1.02e-05	8.6e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—IL6—lung cancer	1.02e-05	8.58e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CCND1—lung cancer	1.02e-05	8.55e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—JUN—lung cancer	1.02e-05	8.53e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—STAT3—lung cancer	1.01e-05	8.51e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NRAS—lung cancer	1.01e-05	8.49e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTP1—lung cancer	1.01e-05	8.48e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MMP9—lung cancer	1.01e-05	8.45e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—KRAS—lung cancer	1e-05	8.43e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—POMC—lung cancer	1e-05	8.42e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—CDKN1A—lung cancer	1e-05	8.42e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CCND1—lung cancer	1e-05	8.41e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PTEN—lung cancer	1e-05	8.4e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—JUN—lung cancer	1e-05	8.39e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MMP9—lung cancer	9.89e-06	8.3e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—CDKN1A—lung cancer	9.85e-06	8.27e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CAT—lung cancer	9.84e-06	8.25e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PTEN—lung cancer	9.83e-06	8.25e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CREBBP—lung cancer	9.78e-06	8.21e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—AKT1—lung cancer	9.77e-06	8.2e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MMP9—lung cancer	9.73e-06	8.16e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	9.7e-06	8.13e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MAPK3—lung cancer	9.69e-06	8.13e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PTEN—lung cancer	9.67e-06	8.12e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—AKT1—lung cancer	9.59e-06	8.05e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ABCB1—lung cancer	9.57e-06	8.03e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EP300—lung cancer	9.55e-06	8.01e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—AKT1—lung cancer	9.44e-06	7.92e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—MYC—lung cancer	9.43e-06	7.91e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TYMS—lung cancer	9.4e-06	7.88e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EP300—lung cancer	9.38e-06	7.87e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—GSTM1—lung cancer	9.29e-06	7.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—SRC—lung cancer	9.29e-06	7.79e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.27e-06	7.78e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PIK3CA—lung cancer	9.23e-06	7.74e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EP300—lung cancer	9.23e-06	7.74e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EGFR—lung cancer	9.22e-06	7.74e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ALB—lung cancer	9.16e-06	7.68e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—SRC—lung cancer	9.12e-06	7.65e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—VEGFA—lung cancer	9.04e-06	7.59e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—SRC—lung cancer	8.97e-06	7.53e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STAT3—lung cancer	8.96e-06	7.51e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NRAS—lung cancer	8.93e-06	7.49e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TP53—lung cancer	8.93e-06	7.49e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—VEGFA—lung cancer	8.88e-06	7.45e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CYP1A1—lung cancer	8.81e-06	7.39e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—STAT3—lung cancer	8.79e-06	7.38e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NRAS—lung cancer	8.77e-06	7.36e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—VEGFA—lung cancer	8.74e-06	7.33e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ERCC2—lung cancer	8.73e-06	7.33e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—KRAS—lung cancer	8.71e-06	7.31e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STAT3—lung cancer	8.65e-06	7.26e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NRAS—lung cancer	8.63e-06	7.24e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MAPK3—lung cancer	8.56e-06	7.18e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRAS—lung cancer	8.54e-06	7.17e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MAPK3—lung cancer	8.4e-06	7.05e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—MYC—lung cancer	8.32e-06	6.98e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MAPK3—lung cancer	8.27e-06	6.93e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—IL6—lung cancer	8.17e-06	6.86e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—MYC—lung cancer	8.17e-06	6.85e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EGFR—lung cancer	8.14e-06	6.83e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CB—lung cancer	8.08e-06	6.78e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—MYC—lung cancer	8.04e-06	6.74e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTGS2—lung cancer	8.01e-06	6.72e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	8e-06	6.72e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EGFR—lung cancer	7.99e-06	6.7e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EGFR—lung cancer	7.86e-06	6.6e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TP53—lung cancer	7.74e-06	6.5e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—KRAS—lung cancer	7.69e-06	6.45e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—APOA1—lung cancer	7.56e-06	6.34e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—KRAS—lung cancer	7.55e-06	6.33e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—AKT1—lung cancer	7.54e-06	6.33e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—KRAS—lung cancer	7.43e-06	6.23e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRAS—lung cancer	7.41e-06	6.21e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—IL6—lung cancer	7.09e-06	5.95e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	7.06e-06	5.93e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PTEN—lung cancer	6.99e-06	5.86e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	6.94e-06	5.82e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CG—lung cancer	6.9e-06	5.79e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TP53—lung cancer	6.83e-06	5.73e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	6.82e-06	5.73e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TP53—lung cancer	6.71e-06	5.63e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—EP300—lung cancer	6.66e-06	5.59e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TP53—lung cancer	6.6e-06	5.54e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—POMC—lung cancer	6.57e-06	5.51e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—AKT1—lung cancer	6.54e-06	5.49e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRAS—lung cancer	6.54e-06	5.48e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRAS—lung cancer	6.42e-06	5.38e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CREBBP—lung cancer	6.4e-06	5.37e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRAS—lung cancer	6.31e-06	5.3e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—IL6—lung cancer	6.26e-06	5.25e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—IL6—lung cancer	6.14e-06	5.15e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.06e-06	5.09e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—IL6—lung cancer	6.04e-06	5.07e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ALB—lung cancer	5.99e-06	5.02e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—AKT1—lung cancer	5.77e-06	4.84e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—AKT1—lung cancer	5.67e-06	4.75e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—AKT1—lung cancer	5.58e-06	4.68e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.29e-06	4.43e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTGS2—lung cancer	5.24e-06	4.39e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—PIK3CA—lung cancer	4.93e-06	4.13e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PTEN—lung cancer	4.57e-06	3.83e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—EP300—lung cancer	4.36e-06	3.65e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—AKT1—lung cancer	4.03e-06	3.38e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.22e-06	2.7e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—AKT1—lung cancer	2.63e-06	2.21e-05	CbGpPWpGaD
